Literature DB >> 29856527

Diagnosis and management of chronic and refractory immune cytopenias in children, adolescents, and young adults.

Seth J Rotz1, Russell E Ware2,3, Ashish Kumar2,4.   

Abstract

Children, adolescents, and young adults with chronic refractory autoimmune cytopenias represent a rare but challenging group of patients, who are managed frequently by pediatric hematologists. Novel diagnostic tests and genomic discoveries are refining historical diagnoses of Evans syndrome and common variable immunodeficiency, while also elucidating the cellular and molecular basis for these disorders. Genetic characterization of chronic and refractory autoimmune cytopenias has led to targeted therapies with improved clinical outcomes and fewer off-target toxicities. In this review, we focus on the appropriate diagnostic workup, expanded genetic testing, and novel treatment opportunities that are available for these challenging patients.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  AIHA; CVID; Evans syndrome; ITP; alps; cytopenia; immunohematology

Mesh:

Year:  2018        PMID: 29856527     DOI: 10.1002/pbc.27260

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  9 in total

Review 1.  Ethical conundrums in pediatric genomics.

Authors:  Seth J Rotz; Eric Kodish
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

2.  Misdiagnosed thrombocytopenia in children and adolescents: analysis of the Pediatric and Adult Registry on Chronic ITP.

Authors:  Alexandra Schifferli; Andrea Heiri; Paul Imbach; Susanne Holzhauer; Markus G Seidel; Diane Nugent; Marc Michel; Thomas Kühne
Journal:  Blood Adv       Date:  2021-03-23

Review 3.  Treatment of immune-mediated cytopenias in patients with primary immunodeficiencies and immune regulatory disorders (PIRDs).

Authors:  Markus G Seidel
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

4.  Primary Immunodeficiency in Children With Autoimmune Cytopenias: Retrospective 154-Patient Cohort.

Authors:  Emma Westermann-Clark; Cristina Adelia Meehan; Anna K Meyer; Joseph F Dasso; Devendra Amre; Maryssa Ellison; Bhumika Patel; Marisol Betensky; Charles Isaac Hauk; Jennifer Mayer; Jonathan Metts; Jennifer W Leiding; Panida Sriaroon; Ambuj Kumar; Irmel Ayala; Jolan E Walter
Journal:  Front Immunol       Date:  2021-04-22       Impact factor: 7.561

5.  Evans Syndrome in Childhood: Long Term Follow-Up and the Evolution in Primary Immunodeficiency or Rheumatological Disease.

Authors:  Beatrice Rivalta; Daniele Zama; Giovanni Pancaldi; Elena Facchini; Maria Elena Cantarini; Angela Miniaci; Arcangelo Prete; Andrea Pession
Journal:  Front Pediatr       Date:  2019-07-23       Impact factor: 3.418

6.  Autoimmune hemolytic anemia in children: Clinical presentation and treatment outcome.

Authors:  Satyam Arora; Seema Dua; Nita Radhakrishnan; Savitri Singh; Jyotsna Madan; Devajit Nath
Journal:  Asian J Transfus Sci       Date:  2021-11-01

Review 7.  Pathogenesis of Autoimmune Cytopenias in Inborn Errors of Immunity Revealing Novel Therapeutic Targets.

Authors:  Manuela Cortesi; Annarosa Soresina; Laura Dotta; Chiara Gorio; Marco Cattalini; Vassilios Lougaris; Fulvio Porta; Raffaele Badolato
Journal:  Front Immunol       Date:  2022-04-06       Impact factor: 8.786

8.  Primary immune thrombocytopenia: a 'diagnosis of exclusion'?

Authors:  Nathan Visweshwar; Irmel Ayala; Michael Jaglal; Robert Killeen; Lubomir Sokol; Damian A Laber; Arumugam Manoharan
Journal:  Blood Coagul Fibrinolysis       Date:  2022-07-29       Impact factor: 1.061

9.  Peripheral-blood cytopenia, an early indicator of inborn errors of immunity.

Authors:  Helena M Cornelissen; Ernest M Musekwa; Richard H Glashoff; Monika Esser; Moleen Zunza; Deepthi R Abraham; Zivanai C Chapanduka
Journal:  Br J Haematol       Date:  2022-07-06       Impact factor: 8.615

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.